416 related articles for article (PubMed ID: 27175673)
1. Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures.
Huang TW; Chuang PY; Lin SJ; Lee CY; Huang KC; Shih HN; Lee MS; Hsu RW; Shen WJ
Medicine (Baltimore); 2016 May; 95(19):e3626. PubMed ID: 27175673
[TBL] [Abstract][Full Text] [Related]
2. Short-term daily teriparatide improve postoperative functional outcome and fracture healing in unstable intertrochanteric fractures.
Kim SJ; Park HS; Lee DW; Lee JW
Injury; 2019 Jul; 50(7):1364-1370. PubMed ID: 31182230
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
4. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.
Iwata A; Kanayama M; Oha F; Hashimoto T; Iwasaki N
BMC Musculoskelet Disord; 2017 Apr; 18(1):148. PubMed ID: 28388910
[TBL] [Abstract][Full Text] [Related]
5. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
6. Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures.
Huang TW; Huang KC; Lin SJ; Chuang PY; Shih HN; Lee MS; Hsu RW; Shen WJ
BMC Musculoskelet Disord; 2016 Jul; 17():300. PubMed ID: 27435235
[TBL] [Abstract][Full Text] [Related]
7. Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks.
Aspenberg P; Malouf J; Tarantino U; García-Hernández PA; Corradini C; Overgaard S; Stepan JJ; Borris L; Lespessailles E; Frihagen F; Papavasiliou K; Petto H; Caeiro JR; Marin F
J Bone Joint Surg Am; 2016 Nov; 98(22):1868-1878. PubMed ID: 27852903
[TBL] [Abstract][Full Text] [Related]
8. Does short-term weekly teriparatide improve healing in unstable intertrochanteric fractures?
Kim SJ; Park HS; Lee DW; Lee JW
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018802485. PubMed ID: 30296889
[TBL] [Abstract][Full Text] [Related]
9. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
[TBL] [Abstract][Full Text] [Related]
10. The effects of bone-substitute augmentation on treatment of osteoporotic intertrochanteric fractures.
Chang FC; Chuang PY; Lee CY; Lee CY; Chou YC; Huang TW; Huang KC; Shih HN; Lee MS
Biomed J; 2021 Dec; 44(6):717-726. PubMed ID: 35166210
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of teriparatide in in improving healing rates and bone-turnover markers of osteoporotic hip fracture: a meta-analysis.
Luo L; Lin J; Ma W; Fan J
J Pak Med Assoc; 2024 Apr; 74(4):741-751. PubMed ID: 38751272
[TBL] [Abstract][Full Text] [Related]
12. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
13. Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study.
Kawabata A; Yoshii T; Hirai T; Ushio S; Kaito T; Yamashita T; Fujiwara H; Nagamoto Y; Matsuoka Y; Suzuki H; Nishimura H; Terai H; Tamai K; Tagami A; Yamada S; Adachi S; Watanabe K; Katsumi K; Ohashi M; Shibuya Y; Harimaya K; Kawaguchi K; Yokoyama N; Oishi H; Doi T; Kimura A; Inoue H; Inoue G; Miyagi M; Saito W; Nakano A; Sakai D; Nukaga T; Ikegami S; Shimizu M; Futatsugi T; Ohtori S; Furuya T; Orita S; Imagama S; Ando K; Kobayashi K; Kiyasu K; Murakami H; Yoshioka K; Seki S; Hongo M; Kakutani K; Yurube T; Aoki Y; Oshima M; Takahata M; Iwata A; Endo H; Abe T; Tsukanishi T; Nakanishi K; Watanabe K; Hikata T; Suzuki S; Isogai N; Okada E; Funao H; Ueda S; Shiono Y; Nojiri K; Hosogane N; Ishii K
BMC Musculoskelet Disord; 2020 Jul; 21(1):420. PubMed ID: 32611386
[TBL] [Abstract][Full Text] [Related]
14. Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.
Bhandari M; Jin L; See K; Burge R; Gilchrist N; Witvrouw R; Krohn KD; Warner MR; Ahmad QI; Mitlak B
Clin Orthop Relat Res; 2016 May; 474(5):1234-44. PubMed ID: 26932738
[TBL] [Abstract][Full Text] [Related]
15. Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS).
Ljunggren O; Benhamou CL; Dekker J; Kapetanos G; Kocjan T; Langdahl BL; Napoli N; Petto H; Nikolić T; Lindh E
Curr Med Res Opin; 2014 Aug; 30(8):1607-16. PubMed ID: 24720366
[TBL] [Abstract][Full Text] [Related]
16. Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Jeon S; Yu D; Kim S; Kim SW; Jeon I
Osteoporos Int; 2024 May; 35(5):795-804. PubMed ID: 38261013
[TBL] [Abstract][Full Text] [Related]
17. Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures.
Liu Z; Li CW; Mao YF; Liu K; Liang BC; Wu LG; Shi XL
Orthop Surg; 2019 Jun; 11(3):380-385. PubMed ID: 31058448
[TBL] [Abstract][Full Text] [Related]
18. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
19. A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation.
Shin WC; Moon NH; Jang JH; Seo HU; Suh KT
Bone; 2019 Nov; 128():115033. PubMed ID: 31398503
[TBL] [Abstract][Full Text] [Related]
20. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study.
Ljunggren Ö; Barrett A; Stoykov I; Langdahl BL; Lems WF; Walsh JB; Fahrleitner-Pammer A; Rajzbaum G; Jakob F; Karras D; Marin F
BMC Musculoskelet Disord; 2013 Aug; 14():251. PubMed ID: 23968239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
